STAT3, Notch1/2, Cullin1, TGF-B2, and CREBBP mediate tumor cell proliferation and therapeutic resistance [74–81], and inhibition of the Notch and TGF families sensitizes cancer cells to radiation therapy [79, 82]. This evidence concerns the gene CREBBP and neoplasm.